|

The Spotlight Roundup-Can Psychedelics Help Brain Trauma?

July 21, 2021- This week’s Psychedelic Business News top stories include:
– Wesana Health & The University of Southern Carolina Team up To Develop More Effective Treatments for TBI
– The World’s Largest Psychedelic Trial To Date Achieves Major Milestone
– Awkn Life Sciences Welcomes a World-Renowned Neuroscientist to it’s Team
– Psychedelic Passage On Guiding Individuals on their Psychedelic Journey

AND MORE!

Read The Latest News: https://bit.ly/3kzfMTn

FOLLOW US:
—————————————-
📰 SIGN UP FOR OUR NEWSLETTER:
https://bit.ly/3vZMsYJ

📲 SOCIAL:
Facebook: https://www.facebook.com/PsychedelicS…
Instagram: https://www.instagram.com/psycspotlight/
Twitter: https://twitter.com/PsycSpotlight
LinkedIn: https://www.linkedin.com/company/psyc…

#psychedelics #news #mentalhealth

source

Similar Posts

  • MindMed Near Term CATALYSTS & Nasdaq Debrief [MMED / MNMD]

    So what happened with MindMed (MMED / MNMD) on the day on the NASDAQ uplisting? As we all know, MindMed announced on 23rd of April that the MMEDF stock will uplist on NASDAQ on April 27th under ticker MNMD. for MMED : NEO owners, the stock ticker will remain the same, adjusted to US ER.

    Ever since, we all speculated on what will happen to the MindMed stock on April 27 and what will be it’s closing price? On April 26th, the stock price rose to near all time highs and a lot of retail investors thought that on the 27th, the run will continue. MindMed’s move to the Nasdaq was to increase the visibility of its stock in hopes of reaching out to a new group of retail and institutional investors.

    Unfortunately, the plan didn’t go so well. While MindMed opened at the previous all time high, the stock dropped throughout the day. MindMed, (MNMD) closed today after its first day on the Nasdaq at: $4.02, down 16%,
    most probably due to investors who took some profits, which was one of the scenarios in our previous video on MindMed Nasdaq Uplisting price predictions.

    So in this video, I’ll share my thoughts on today’s MMED / MNMD stock events and then discuss the near time future catalysts for MindMed.

    Timestamps:
    0:00 – Intro
    1:27 – Thoughts on MindMed (MNMD) first trading day on NASDAQ
    6:05 – MindMed catalyst #1 – Atai’s IPO
    7:37 – PSIL ETF coming soon
    9:58 – Phase 2a results for MindMed’s Project LUCY
    11:38 – Project LUCY starting Phase2b in Q4 this year
    12:26 – Completion of Phase 1 Trial for Project Layla (18-MC)
    13:08 – Completion of Phase 1 LSD Neutralizer Study

    Remember to Like, Subscribe, and SMASH that notifications bell to keep up to date on all the latest Psychedelic Stocks news!
    Follow us on social media! 🙌

    Instagram: @psychedelicinvestor
    Email: thepsychedelicinvestor@gmail.com
    Facebook: @thepsychedelicinvestor
    Music: www.bensound.com
    https://benzinga.grsm.io/jameshallifax1834
    https://benzinga.grsm.io/thepsychedelicinvestor

    Links to Clinical trials :

    https://clinicaltrials.gov/ct2/results?cond=&term=LSD&cntry=&state=&city=&dist=
    https://clinicaltrials.gov/ct2/show/NCT03153579?term=LSD&draw=2&rank=5&fbclid=IwAR3fZtlvGX2UAFI0pOkFNANqVpU8ac5pLBTyfwfbd3D4v_1OW61fZLFZGkY

    https://clinicaltrials.gov/ct2/show/NCT03604744?term=LSD&draw=2&rank=6&fbclid=IwAR3fZtlvGX2UAFI0pOkFNANqVpU8ac5pLBTyfwfbd3D4v_1OW61fZLFZGkY

    https://mindmed.co/wp-content/uploads/2021/04/MindMed-Corporate-Presentation-4.27.2021.pdf

    DISCLAIMER: I am not a financial adviser nor a CPA. These videos are for educational and entertainment purposes only. Investing of any kind involves risk. While it is possible to minimize risk, your investments are solely your responsibility. It is imperative that you conduct your own research. I am merely sharing my opinion with no guarantee of gains or losses on investments.

    All of the information in this video is public information that James (The Psychedelic Investor) believes to be reliable but it is not guaranteed to be 100% accurate and as such should not be used as advice. Any opinions or thoughts from James (The Psychedelic Investor) are subject to change.

    #MindMed #MindMedNasdaq #MindMedstock

  • MindMed Conference Call Recap & My THOUGHTS (MMED / MNMD)

    Hey guys! Here’s the recap of MindMed’s (MMED / MNMD/ MMQ) Q1 conference call. They added lots of color on their different projects, and provided us with a lot of interesting new information. So, in this episode, we will cover a few topics. These are:

    1. MindMed’s Mission
    2. Their Talent acquisition
    3. The Progress of their different clinical trials
    4. The future

    Timestamps:
    0:00 – Intro
    1:59 – MindMed’s Mission
    4:36 – MMED’s talent acquisition
    7:24 – MindMed’s clinical trial progress
    10:48 – Psychiatry department : Project Lucy
    14:17 – Addiction department : Project Layla (18MC)
    18:33 – Pain department: Project Angie to treat pain card
    22:56 – Neurology department: Project Flow using LSD microdosing to treat ADHD
    23:43 – MindMed (MMED / MNMD) and its future plans

    Enjoy!

    Remember to Like, Subscribe, and SMASH that notifications bell to keep up to date on all the latest Psychedelic Stocks news!
    Follow us on social media! 🙌

    Instagram: @thepsychedelicinvestor
    Email: thepsychedelicinvestor@gmail.com
    Facebook: @thepsychedelicinvestor
    Music: www.bensound.com
    Video editing: @themyaholy
    https://benzinga.grsm.io/jameshallifax1834
    https://benzinga.grsm.io/thepsychedelicinvestor

    DISCLAIMER: I am not a financial adviser nor a CPA. These videos are for educational and entertainment purposes only. Investing of any kind involves risk. While it is possible to minimize risk, your investments are solely your responsibility. It is imperative that you conduct your own research. I am merely sharing my opinion with no guarantee of gains or losses on investments.

    All of the information in this video is public information that James (The Psychedelic Investor) believes to be reliable but it is not guaranteed to be 100% accurate and as such should not be used as advice. Any opinions or thoughts from James (The Psychedelic Investor) are subject to change.

    #MindMed #PsychedelicStocks #MNMD

  • Exploring Integrative Therapy and Altered States of Consciousness with Lana Rados, Intronaut

    In today’s episode, Lana describes her journey from being a clinically-focused empiricist to eventually opening up to the possibilities of mystical states of consciousness, discusses how plant medicine can be effective for healing all levels of trauma, and updates us on her view of the clinical and spiritual perspectives of psychedelic-assisted psychotherapy.

  • PSYCHEDELICS & The Mental Health Crisis In America: Anxiety, Depression And Addiction ALL TIME HIGHS

    The mental healthcare crisis is escalating: Are Psychedelic Medicines the Solution? Can psychedelics health North America fight against anxiety, depression and addiction?

    It is well known that during these unprecedented times of lockdowns and fear, our society’s mental health has taken a toll. Unfortunately, few realize how dire the situation has become.
    In some respects, this pandemic has accelerated other health care crises: such as the addiction and overdose crisis, the depression crisis, and the anxiety crisis.
    These crises can be hard to see when the illnesses are often hidden by those that are experiencing them, out of shame.

    However, we can’t start talking about solutions to the problem until we see how big the problem is.
    Therefore, in this episode, we are going to take a look at:
    1. Some of the data regarding addiction, depression, and anxiety levels during the pandemic, and show you how stark this increase has been;

    2. We will discuss a novel solution which has a lot of evidence backing it up: using psychedelics like magic mushrooms and LSD to treat these maladies of the mind;

    Enjoy the episode!

    Timestamps:
    0:00 – Intro
    1:37 – Increased rates of Anxiety, Depression & Addiction in North America
    6:24 – Psychedelic inspired medicines – potential solutions?

    Follow us on social media! 🙌
    Instagram: @thepsychedelicinvestor
    Facebook: @thepsychedelicinvestor

    Want to collaborate? Send us an email at:
    thepsychedelicinvestor@gmail.com

    Music from:
    www.bensound.com

    Video editing: @themyaholy
    Check out our Benziga discounts
    https://benzinga.grsm.io/jameshallifax1834
    https://benzinga.grsm.io/thepsychedelicinvestor

    Links:
    Rates of addiction since the epidemic began:
    https://www.kten.com/story/44309290/continued-increase-in-substance-abuse-after-pandemic

    Rates of overdose:
    https://www.google.com/url?q=https://www.forbes.com/sites/niallmccarthy/2021/07/16/us-experiences-a-historic-spike-in-overdose-deaths-infographic/?sh5452ed443650&sa=D&source=editors&ust=1626828792173000&usg=AOvVaw3NuNLOX7F8X_pg9Uh0Rnhv

    Rates of depression:
    https://www.meetfieldtrip.com/news/news-details/2021/More-than-80-of-Americans-report-one-or-more-symptoms-of-depression-and-many-have-turned-to-substances-to-cope-with-negative-emotions-during-COVID-19-Pandemic-according-to-Field-Trip-Healths-First-Annual-State-of-Mind-Survey/default.aspx
    https://www.nature.com/articles/d41586-021-00175-z

    Research into psychedelics as potential alternative treatments

    Psilocybin: A potential treatment for depression:
    https://newatlas.com/health-wellbeing/psilocybin-therapy-major-depression-trial-results-johns-hopkins/
    https://www.imperial.ac.uk/news/219413/magic-mushroom-compound-performs-well-antidepressant/

    Psilocybin : A potential cure for Smoking:
    https://pubmed.ncbi.nlm.nih.gov/27441452/

    Ibogaine: A potential cure for addiction:
    https://www.tandfonline.com/doi/full/10.1080/00952990.2017.1310218

    DISCLAIMER: I am not a financial adviser nor a CPA. These videos are for educational and entertainment purposes only. Investing of any kind involves risk. While it is possible to minimize risk, your investments are solely your responsibility. It is imperative that you conduct your own research. I am merely sharing my opinion with no guarantee of gains or losses on investments.

    All of the information in this video is public information that James (The Psychedelic Investor) believes to be reliable but it is not guaranteed to be 100% accurate and as such should not be used as advice. Any opinions or thoughts from James (The Psychedelic Investor) are subject to change.

    #ANXIETY#DEPRESSION #PsychedelicTherapy